SEATTLE, June 10 /PRNewswire-FirstCall/ --
Immunex Corporation (Nasdaq: IMNX) has scheduled a presentation at the
following investor conference in June 2002. The conference date and location
is as follows:
-- Goldman Sachs Global Healthcare Conference
June 13, 2002
Laguna Niguel, California
For information about available webcasts and replays, visit the Investor
Relations page on the Immunex website at http://www.immunex.com/investor_fs3.html .
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: Except for the historical information contained herein, this news
release contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the Securities and Exchange Commission, including but not limited to
risks described under the caption "Important Factors That May Affect Our
Business, Our Results of Operation and Our Stock Price" within our most
recently filed Form 10-Q. The forward-looking statements contained in this
news release represent our judgment as of the date of this release. Immunex
undertakes no obligation to publicly update any forward-looking statements.
An electronic version of this news release -- as well as additional
information about Immunex of interest to investors, customer, future employees
and patients -- is available on the Immunex home page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
CONTACT:
media, Robin Shapiro, +1-206-389-4040, or
investors, Mark Leahy, +1-206-389-4363, both of Immunex
Corporation
|
